Cytokinetics, Incorporated

Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised or declining. Founded in South San Francisco by pioneers in muscle biology, the company has spent more than 25 years targeting the sarcomere, the foundation of muscle contraction. Its pipeline of investigational medicines addresses diseases of high unmet need, including heart failure, hypertrophic cardiomyopathy, and neuromuscular disease.